Lens opacity as a serious side effect following chelation therapy in beta thalassemia: A comparison between deferoxamine and deferasirox; randomized double-blinded clinical trial
Introduction: Ocular toxicity is a serious side effect following chelation therapy in patients suffering from major beta-thalassemia. Objectives: We aimed to assess ocular toxicity (lens opacity) of the Iranian brand of deferasirox named "Osveral" marketed by an Iranian company and also to...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2019-01-01
|
| Series: | Journal of Preventive Epidemiology |
| Subjects: | |
| Online Access: | http://jprevepi.com/PDF/jpe-62 |